FDA Experts to Vote on Bayer AG’s (Jobs) Trasylol Fate

WASHINGTON (AP) -- The Food and Drug Administration will ask an outside panel of medical experts Wednesday whether a Bayer AG drug used to control bleeding in patients undergoing heart bypass surgery should stay on the market.
MORE ON THIS TOPIC